The use of propofol for induction of anaesthesia in dogs premeditated with acepromazine, butorphanol and acepromazine-butorphanol
- 8 January 1997
- journal article
- research article
- Published by Taylor & Francis in New Zealand Veterinary Journal
- Vol. 45 (4) , 129-134
- https://doi.org/10.1080/00480169.1997.36012
Abstract
Cardiovascular, pulmonary and anaesthetic-analgesic responses were evaluated in 18 male and female dogs to determine the effect of the injectable anaesthetic propofol used in conjuction with acepromazine and butorphanol. The dogs were randomly divided into three groups. Dogs in Group A were premeditated with 0.1 mg/kg of intramuscular acepromazine followed by an induction dose of 4.4 mg/kg of intravenous propofol; Group B received 0.2 mg/kg of intramuscular butorphanol and 4.4 mg/kg of intravenous propofol; dogs in Group AB were administered a premeditation combination of 0.1 mg/kg of intramuscular acepromazine and 0.2 mg/kg of intramuscular butorphanol, followed by induction with 3.3 mg/kg of intravenous propofol. The induction dose of propofol was given over a period of 30–60 seconds to determine responses and duration of anaesthesia. Observations recorded in the dogs included heart and respiratory rates, indirect arterial blood pressures (systolic, diastolic and mean), cardiac rhythm, end-tidal CO2 tension, oxygen saturation, induction time, duration of anaesthesia, recovery time and adverse reactions. The depth of anaesthesia was assessed by the response to mechanical noxious stimuli (tail clamping), the degree of muscle relaxation and the strength of reflexes. Significant respiratory depression was seen after propofol induction in both groups receiving butorphanol with or without acepromazine. The incidence of apnea was 4/6 dogs in Group B, and 5/6 dogs in Group AB. The incidence of apnea was also correlated to the rate of propofol administration. Propofol-mediated decreases in arterial blood pressure were observed in all three groups. Moderate bradycardia (minimum value > 55 beats/min) was observed in both Groups B and AB. There were no cardiac dysrhythmias noted in any of the 18 dogs. The anaesthetic duration and recovery times were longer in dogs premeditated with acepromazineibutorphanol.Keywords
This publication has 14 references indexed in Scilit:
- Butorphanol Tartrate for Partial Reversal of Oxymorphone‐Induced Postoperative Respiratory Depression in the DogVeterinary Surgery, 1994
- A Clinical Comparison of Oxymorphone‐Acepromazine and Butorphanol‐Acepromazine Sedation in DogsVeterinary Surgery, 1992
- PropofolAnesthesiology, 1989
- Clinical evaluation of propofol as an intravenous anaesthetic agent in cats and dogsVeterinary Record, 1989
- PropofolDrugs, 1988
- ADVERSE EFFECTS OF OPIOID ANALGESIC DRUGSBritish Journal of Anaesthesia, 1987
- PHARMACOLOGY OF AN EMULSION FORMULATION OF ICI 35 868British Journal of Anaesthesia, 1984
- Book ReviewAnesthesiology: A manual of concept and managementNew England Journal of Medicine, 1980
- ButorphanolDrugs, 1978
- Hemodynamic and respiratory effects of morphine and butorphanolClinical Pharmacology & Therapeutics, 1978